Suresh Balu has been named Associate Dean for Innovation and Partnership for the Duke University School of Medicine, effective immediately. In this new role, Suresh will be responsible for creating, implementing, and sustaining innovation and partnership initiatives for the School of Medicine, specifically, to support the strategic priorities for clinical and translational research. He will be responsible for developing and strengthening relationships across Duke Health and Duke University and with key stakeholders external to Duke.
Suresh currently serves as program director for the Duke Institute for Health Innovations (DIHI) and director of strategy and innovation for the Duke Clinical and Translational Science Institute (CTSI). He will retain his role in the DIHI. Suresh’s experience prior to joining Duke spans academia, management consulting, venture capital and private equity. As a corporate and competitive strategy consultant, Suresh worked with leading life sciences and technology firms to develop strategies for innovation, revenue generation, organizational restructuring and product portfolio planning. He was responsible for program management, market and product strategy. Suresh has operational and business development experience in Asia and Europe, where he helped to establish sales channels serving government and academic clients. He is an inventor named on several US and international patents, and in 2015 was named one of the 50 Top Healthcare IT Experts by HealthData Management magazine. Suresh holds an MBA degree and an MS in Computer Science degree as well as a Master’s degree in Informatics.